The PCM Scientific team recently hosted the IOTOD (Improving Outcomes in the Treatment of Opioid Dependence) summer webinar: ‘Long-acting buprenorphine in the treatment of opioid dependence: striking the balance between greater freedom and strong engagement.’


This summer educational webinar was led by Wales-based Dr Julia Lewis and joined by Dr Steve Brinksman who is based in Birmingham, where they discussed the significance of taking a holistic approach when providing treatment for opioid dependence.

The event also explored the sharing of best-practice involving opioid substitution treatment particularly when using long-acting buprenorphine (LAB) formulations to support adherence, good quality of life and mental health, and overall treatment success. Both speakers shared their own examples of their own personal patient stories and the impact this treatment has had on their patients.

The webinar was a great success with 212 in attendance and reaching places including the UK, many countries across Europe and even as far as New Zealand. Accessing our community of healthcare professionals via our media brands as well as the well-established IOTOD community, the webinar welcomed addiction specialists, psychiatrists, GPs, community pharmacists, primary care nurses and other healthcare professional managing patients with opioid dependence and associated comorbidities.

The event concluded with a lively Q&A session, with faculty concluding “We have to have a holistic care plan that is tailored to the needs of the actual patient that they are going to find attractive, and they are therefore going to engage with”.

The IOTOD webinar was supported by arms-length funding from Camurus and the archived version will soon be available on the IOTOD website.